Director, Haematology External Innovation & S&E

CSL; Glattbrugg; Hybrid; CHF 220.000 - 320.000; Vollzeit

Zusammenfassung

CSL is expanding its external innovation capability and seeks a Director of Search & Evaluation to shape the Haematology portfolio. The role is hybrid onsite across Zurich (CH), Maidenhead (UK), Waltham (US), or King of Prussia (US).

You will lead strategic sourcing, evaluate preclinical to Phase 1 assets, and drive early partnering strategies with BD. The position requires deep Haematology expertise, a PhD or MD, and a proven track record in due diligence and early-stage deal making.

Qualifikationen

• Significant tenure in biopharma with external innovation or business development experience.
• Advanced degree required (PhD, MD, or equivalent).
• Deep scientific expertise in Haematology.
• Proven track record of leading due diligence and closing early‑stage deals.

Aufgaben

• Serve as the senior Early S&E leader within the TALT, influencing therapeutic strategy and ensuring external innovation priorities are integrated into portfolio planning.
• Lead proactive sourcing and scouting for preclinical and Phase 1 assets, building a robust pipeline aligned with TA strategy.
• Co‑lead internal meetings focused on evaluating and prioritizing New Product Opportunities within Haematology.
• Develop and execute early partnering strategies, including onboarding approaches and competitive positioning for priority assets.
• Drive cross‑functional due diligence for each opportunity, coordinating scientific, clinical, regulatory, and commercial assessments.
• Transaction execution: partner with BD and Regional Ecosystem Leads to advance opportunities through negotiation and deal close.
• Represent the TA externally, leading sourcing activities at conferences and cultivating relationships with biotech, academia, and investment communities.

Kenntnisse

Strategic sourcing

External innovation

Due diligence

Partnership development

Networking

Ausbildung

PhD

MD

Advanced degree

Jobbeschreibung

CSL is expanding its external innovation capability and seeks a Director of Search & Evaluation to shape the Haematology portfolio. The role is hybrid onsite across Zurich (CH), Maidenhead (UK), Waltham (US), or King of Prussia (US).

You will lead strategic sourcing, evaluate preclinical to Phase 1 assets, and drive early partnering strategies with BD. The position requires deep Haematology expertise, a PhD or MD, and a proven track record in due diligence and early-stage deal making.